Schreiner MediPharm begins mass production of Needle-Trap

Published: 29-Sep-2010
Packaging Drug Delivery Pharmaceutical

Offers protection against needlestick injuries

Schreiner MediPharm begins mass production of Needle-Trap
Schreiner MediPharm has begun mass production of Needle-Trap, its economical and safe solution that protects against needlestick injuries.

Needle-Trap consists of a syringe label with integrated needle protection that secures the blood-contaminated needle after injection, thus protecting healthcare professionals from needlestick injuries.

The German company says Needle-Trap’s compact design and easy integration into existing production processes means a low-cost investment and minimal space requirements for pharmaceutical manufacturers. The combination of a label and needle protection can be processed on conventional labelling equipment with only minor modifications at dispensing speeds of up to 400 units a minute.

Schreiner-MediPharm says Needle-Trap also reduces material and packaging requirements and is thus environmentally friendly.

  • Companies:
  • Schreiner MediPharm
See more

You may also like

Manufacturing
Schreiner MediPharm to present new multifunctional label for pens and autoinjectors at CPHI Milan 2026

Schreiner MediPharm to present new multifunctional label for pens and autoinjectors at CPHI Milan 2026

Read more
Booming markets for GLP-1 drugs pose special challenges to pharmaceutical manufacturers. For this purpose, Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, has developed a new multifunctional label for pens and autoinjectors combining analog and digital security features with additional benefits. Schreiner MediPharm will be presenting the label at CPHI Milan from October 6 to 8, 2026 at Booth 11F61

Trending Articles

  1. Agilent expands Boulder facility with dedicated enzymatic ligation laboratory for oligonucleotide therapeutics The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approaches as oligonucleotide pipeline demand grows
  2. Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month Piramal Pharma Solutions (“PPS”), a leading global Contract Development and Manufacturing Organisation (CDMO) and part of Piramal Pharma Ltd. (“PPL”) (NSE: PPLPHARMA | BSE: 543635), and its partner NP2, a nonprofit generic drug manufacturer, today announced their plans to finish the drug development phase of the generic cancer drug cyclophosphamide in October
  3. Bespak and Upperton partner to deliver integrated nasal drug-device combination product development pathway The collaboration merges Bespak's nasal device portfolio with Upperton's formulation and clinical manufacturing expertise, supporting liquid, soft mist and dry powder formats as CNS and nose-to-brain delivery applications accelerate
  4. SCHOTT Pharma makes decarbonisation measurable Validated carbon footprint tool supports informed Scope 3 reduction decisions for pharmaceutical packaging
  5. Faller Packaging unveils new look and complex packaging solutions at CPhI 2026 At Booth 11F93 in Hall 11, the company will not only be showcasing its new look, it will also present solutions for sensitive primary products such as auto-injectors, syringes and vials, as well as pre-assembled combination packs comprising a folding carton and a leaflet

You may also like

Manufacturing
Schreiner MediPharm to present new multifunctional label for pens and autoinjectors at CPHI Milan 2026

Schreiner MediPharm to present new multifunctional label for pens and autoinjectors at CPHI Milan 2026

Booming markets for GLP-1 drugs pose special challenges to pharmaceutical manufacturers. For this purpose, Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, has developed a new multifunctional label for pens and autoinjectors combining analog and digital security features with additional benefits. Schreiner MediPharm will be presenting the label at CPHI Milan from October 6 to 8, 2026 at Booth 11F61
Packaging
Functional labels with integrated gas barrier reduce oxygen ingress into COC syringes

Functional labels with integrated gas barrier reduce oxygen ingress into COC syringes

Specialty labels with a barrier function from Schreiner MediPharm offer pharmaceutical manufacturers a validated solution that can be flexibly adapted to a variety of COC syringes and substances
Packaging
Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

The global market for weight management drugs is seeing dynamic growth and increases the demand for powerful self-injection systems
Packaging
FINAT Recognises Digital Security Seal from Schreiner MediPharm

FINAT Recognises Digital Security Seal from Schreiner MediPharm

Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, received the prestigious Group Award for Innovation for a newly developed security seal with an integrated digital authentication function in the FINAT Label Competition 2026
You need to be a subscriber to read this article.
Click here to find out more.
Packaging
RFID and smart labels: a new frontier in pharma packaging

RFID and smart labels: a new frontier in pharma packaging

Smart RFID and NFC labels are moving beyond simple identification to enable real-time traceability, automated inventory management and enhanced patient safety, positioning advanced labelling as a strategic tool in pharmaceutical manufacturing and hospital supply chains
Packaging
Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

The Robust RFID labels from Schreiner MediPharm enable the precise tracking of drugs, reduce medication errors and enhance supply efficiency
Packaging
FINAT award recognises pioneering product in “Innovation” category

FINAT award recognises pioneering product in “Innovation” category

At this year’s FINAT Label Competition, Schreiner Group impressed with its Smart Syringe Box from the Schreiner MediPharm business unit
Subscribe now